About the PREVAIL Network

  • Post author:
  • Post category:

The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) network was established through a partnership between local Liberian and international partners, including the U.S. National Institutes of Health, World Health Organization and FHI Clinical, to provide sustainable research infrastructure to address diseases of public health importance.

Continue ReadingAbout the PREVAIL Network

How Can We Streamline the Vaccine Development Process?

  • Post author:
  • Post category:

To address the urgency of vaccine development during a pandemic, innovative strategies are implemented across study design, regulatory processes, recruitment process and more. In this e-book, we describe some of those innovations and argue for incorporating these into the fabric of clinical trials — to establish a “new normal.”

Continue ReadingHow Can We Streamline the Vaccine Development Process?

About FHI Clinical

  • Post author:
  • Post category:

FHI Clinical goes where our expertise is needed. Whether it requires working from a state-of-the-art facility or in a low-tech, rural setting, we provide services tailored to meet your study needs, from protocol design and site assessments to trial planning, implementation and management.

Continue ReadingAbout FHI Clinical